Warren Urges FTC to Protect Cancer Patients, Closely Scrutinize Acquisitions of Oncology Practices for Anticompetitive Effects
October 29, 2024
October 29, 2024
WASHINGTON, Oct. 29 -- Sen. Elizabeth Warren, D-Massachusetts, issued the following news release:
Today, U.S. Senator Elizabeth Warren (D-Mass.) wrote to Chair Lina Khan of the Federal Trade Commission (FTC) urging the FTC to closely scrutinize two proposed deals in the oncology market and block them if they violate antitrust law. The deals include McKesson Corporation's (McKesson's) $2.49 billion proposed acquisition of a controlling stake in Core Ventures and Cardinal Health's (Ca . . .
Today, U.S. Senator Elizabeth Warren (D-Mass.) wrote to Chair Lina Khan of the Federal Trade Commission (FTC) urging the FTC to closely scrutinize two proposed deals in the oncology market and block them if they violate antitrust law. The deals include McKesson Corporation's (McKesson's) $2.49 billion proposed acquisition of a controlling stake in Core Ventures and Cardinal Health's (Ca . . .